Uncategorized
Featured Stories
DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call
DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement
DaVita Inc. to Participate in TD Cowen’s 46th Annual Health Care Conference
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
-
DaVita Clinical Research to Present 12 Abstracts at American Society of Nephrology Kidney Week 2016
DaVita Clinical Research, a specialty contract research organization with services spanning the full spectrum of drug and device development, today announced that company representatives and…
-
DaVita Supports National Diabetes Month
DaVita Inc. (NYSE: DVA), a leading independent medical group and a leading provider of kidney care services in the United States, joins the fight against diabetes during National Diabetes Month by…
-
DaVita Inc. 3rd Quarter 2016 Results
DaVita Inc. (NYSE: DVA) today announced results for the quarter ended September 30, 2016. Net income attributable to DaVita Inc. for the three months ended September 30, 2016 was $571 million, or…
-
DaVita Announces Change for Medicaid Patients Seeking Affordable Care Act Plan Coverage
DaVita Kidney Care (“DaVita”), a division of DaVita Inc. (NYSE: DVA), a leading provider in kidney care services, today announced information concerning its patients enrolled in plans governed by…
-
DaVita’s Annual Bike Ride Raises over $1.2 Million
DaVita Inc. (NYSE: DVA), a leading independent medical group and a leading provider of kidney care services in the United States, today announced the total in donations raised during Tour DaVita,…